Hua Sun

Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis

Mechanisms of hepatic stellate cell activation

Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice

Hepatic Stellate Cells and Liver Fibrosis

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

TGF-β: the master regulator of fibrosis

Hepatocellular carcinoma

Suppression of type I collagen production by microRNA-29b in cultured human stellate cells

Down‐regulation of cyclin E1 expression by microrna‐195 accounts for interferon‐β‐induced inhibition of hepatic stellate cell proliferation

Mechanisms of NAFLD development and therapeutic strategies

Evolving challenges in hepatic fibrosis

miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells

Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis

Hepatitis C Virus RNA Functionally Sequesters miR-122

Fibrosis — A Common Pathway to Organ Injury and Failure

MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis